These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 15623627

  • 1. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 2. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 3. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R, Jerónimo C, Hoque MO, Nomoto S, Carvalho AL, Costa VL, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 20; 14(5):1274-8. PubMed ID: 15894685
    [Abstract] [Full Text] [Related]

  • 4. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb 20; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 5. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2002 May 20; 11(5):445-50. PubMed ID: 12010858
    [Abstract] [Full Text] [Related]

  • 6. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R, Ribeiro FR, Fonseca D, Hoque MO, Carvalho AL, Costa VL, Pinto M, Oliveira J, Teixeira MR, Sidransky D, Jerónimo C.
    Clin Cancer Res; 2007 Oct 15; 13(20):6122-9. PubMed ID: 17947477
    [Abstract] [Full Text] [Related]

  • 7. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH.
    J Pathol; 2007 Feb 15; 211(3):269-77. PubMed ID: 17139617
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R, Jerónimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, Oliveira J, Lopes C, Sidransky D.
    Mol Cancer Res; 2006 Jan 01; 4(1):1-8. PubMed ID: 16446401
    [Abstract] [Full Text] [Related]

  • 10. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 11. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 12. Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.
    Jerónimo C, Henrique R, Hoque MO, Ribeiro FR, Oliveira J, Fonseca D, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4010-4. PubMed ID: 15217932
    [Abstract] [Full Text] [Related]

  • 13. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O.
    Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525
    [Abstract] [Full Text] [Related]

  • 14. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 15; 7(6):531-6. PubMed ID: 9641498
    [Abstract] [Full Text] [Related]

  • 15. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D.
    Cancer Res; 2004 Aug 01; 64(15):5511-7. PubMed ID: 15289362
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.
    J Natl Cancer Inst; 2006 Jul 19; 98(14):996-1004. PubMed ID: 16849682
    [Abstract] [Full Text] [Related]

  • 17. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.
    Urology; 2008 Jan 19; 71(1):161-7. PubMed ID: 18242387
    [Abstract] [Full Text] [Related]

  • 18. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
    Carvalho JR, Filipe L, Costa VL, Ribeiro FR, Martins AT, Teixeira MR, Jerónimo C, Henrique R.
    Apoptosis; 2010 Aug 19; 15(8):956-65. PubMed ID: 20464497
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
    Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4730-4. PubMed ID: 14581343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.